Posi-Shield Advanced™ Low Dermatitis Nitrile: Violet Blue Exam Gloves for Sensitive Skin, 100 per box

Posi-Shield Advanced is a Low Dermatitis Certified, accelerator-free nitrile examination glove designed for healthcare professionals who experience or are at risk for contact dermatitis. Unlike standard nitrile gloves, Posi-Shield Advanced is manufactured using breakthrough cross-linking technology that eliminates chemical accelerators — the leading cause of glove-related skin reactions — delivering a clinically safer, dermatologically validated option for medical and dental professionals.

Posi-Shield Advanced nitrile exam gloves are available in five sizes: Extra Small, Small, Medium, Large, and Extra Large. The full size range ensures that every member of a clinical team — from the smallest to the largest hands — can access the same level of accelerator-free, low-dermatitis protection.

Posi-Shield Advanced is offered exclusively in violet blue. The distinctive colorway makes it immediately identifiable on the glove shelf — a practical advantage for facilities that stock multiple glove types and need quick visual differentiation at the point of care.

Each box of Posi-Shield Advanced contains 100 gloves. Cases are sold in configurations of 12 boxes per case, totaling 1,200 gloves per case. This bulk format is designed to meet the high-volume demands of hospitals, dental offices, surgical centers, and clinical supply teams managing ongoing inventory.

A Type IV allergy — also known as contact dermatitis — is a delayed hypersensitivity reaction triggered by specific chemical allergens, most commonly the chemical accelerators used in the manufacturing of both latex and synthetic gloves. Unlike immediate allergic reactions, Type IV responses typically develop 6 to 48 hours after exposure. In a clinical context, Type IV glove reactions are among the most prevalent and underdiagnosed occupational health issues affecting healthcare workers. Research indicates that 28% of all glove-related reactions are linked directly to chemical accelerators or Type IV allergy.

Contact dermatitis is a skin condition that occurs when the skin is exposed to an allergen present in glove components. Symptoms — including an itchy, red rash or small fluid-filled blisters — typically appear within 6 to 48 hours of exposure. If left unaddressed, contact dermatitis can progress from mild irritation to severe, chronic skin damage. In the most serious cases, it can become career-ending for healthcare professionals who rely on their hands every day. Early identification and glove substitution are the most effective interventions.

Contact dermatitis ranges from mild and manageable — when caught early — to severe and career-altering when ignored or undertreated. The skin is the body's first line of defense against bloodborne pathogens and infectious disease. When skin integrity is compromised by persistent irritation or allergic reaction, a clinician's risk of exposure to dangerous pathogens increases significantly. Resolving contact dermatitis early is not just a comfort issue — it is a patient safety and occupational health imperative.

Chemical accelerators are sulphur-based compounds used during the glove manufacturing process to vulcanize — or cure — the rubber material. While they are effective production agents, these accelerators leave residual chemical traces in the finished glove. For many wearers, direct skin contact with those residues triggers Type IV allergic reactions and dermatitis. Chemical accelerators are responsible for the majority of skin reactions associated with nitrile and latex glove use in clinical settings.

An accelerator-free glove is one manufactured using an advanced cross-linking technology that completely bypasses the use of chemical accelerators during production. The result is a finished glove with no sulphur-based accelerator residue — eliminating the primary chemical trigger for Type IV allergic reactions and contact dermatitis. Posi-Shield Advanced uses this breakthrough technology to deliver full exam-grade protection without the dermatological risk associated with conventional manufacturing methods.

Low Dermatitis Potential is a documented performance designation — not a marketing phrase. It applies to gloves that have been independently tested and verified to meet three specific criteria: zero detectable chemical accelerator residue, no capacity to induce skin irritation, and no potential to cause sensitization reactions. For a dental practice manager, infection control coordinator, or procurement lead, this designation provides evidence-based assurance — grounded in material testing and manufacturing documentation — that the glove will not contribute to occupational dermatitis in your clinical staff. It is the kind of specification that matters when you are responsible for the skin health of an entire team.

Posi-Shield Advanced has been independently tested and certified to confirm the complete absence of chemical accelerators in the finished glove. This certification is not assumed based on the manufacturing process alone — it is verified through accelerator residue testing that confirms zero detectable accelerator content. For clinicians, procurement managers, and infection control teams, this certification provides documented assurance that the glove will not contribute to chemical-induced dermatitis in staff or patients.

The timeline varies by individual. Some users notice improvement within a few hours of switching to accelerator-free gloves like Posi-Shield Advanced. Others with more persistent or chronic dermatitis may require several days to several weeks to experience meaningful skin recovery. Every person's immune and skin response is different — the key is to commit to a consistent trial period rather than making a judgment after a single use. If symptoms persist beyond several weeks of exclusive accelerator-free glove use, a consultation with an occupational health or dermatology specialist is recommended.

Skin is the body's primary barrier against bloodborne pathogens and infectious agents. Compromised skin — whether from an open rash, blistering, or chronic dryness — significantly increases a healthcare worker's vulnerability to occupational exposure. Beyond infection risk, untreated contact dermatitis can escalate in severity over time, lead to permanent skin damage, and in some cases force clinicians to leave the profession entirely. Addressing glove-related dermatitis early — by switching to an accelerator-free option like Posi-Shield Advanced — is one of the most straightforward interventions available.

28% of all glove-related reactions are attributed to chemical accelerators or Type IV (contact dermatitis) allergy. This makes accelerator sensitivity the single most common cause of glove-related skin reactions in clinical settings — ahead of latex and nitrile sensitivities combined. For any facility managing high glove usage across large staff populations, the probability of having accelerator-sensitive individuals on the team is statistically significant.

Yes. Posi-Shield Advanced has been tested in accordance with ASTM D6978 — the Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. Important clinical note: Posi-Shield Advanced should not be used with the chemotherapy drugs CARMUSTINE or THIOTEPA. For all other chemotherapy drug applications covered under ASTM D6978 testing, the glove has demonstrated compliance. Always verify against your facility's chemotherapy handling protocols before use.

ASTM D6978 is the Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. It establishes a standardized testing methodology to evaluate whether a glove material provides adequate barrier resistance when exposed to hazardous chemotherapy agents. Compliance with ASTM D6978 is an important benchmark for any glove used in oncology settings or facilities where hazardous drug handling occurs.

Yes. Posi-Shield Advanced has been tested for use with Fentanyl Citrate. Given the increased prevalence of fentanyl and its derivatives in both clinical care and emergency response environments, barrier resistance to this compound is a critical performance attribute. This testing provides an additional layer of documented protection assurance for first responders, pharmacy staff, and clinical teams handling opioid medications.

ASTM D6319 is the industry standard used to evaluate the safety and performance of nitrile rubber examination gloves for use in medical procedures. It establishes testing benchmarks for critical attributes including physical dimensions, tensile strength, elongation at break, and freedom from holes. Compliance with ASTM D6319 confirms that a nitrile glove meets the baseline performance requirements expected of a medical-grade examination glove.

ASTM D6355-07 is a test method used to assess the probability of an allergic reaction when medical devices — including gloves — come into contact with human tissue. All medical devices must be demonstrated as both safe and effective for their intended use before reaching the clinical environment. This standard is part of the broader biocompatibility evaluation framework that ensures patient-facing medical products do not introduce unnecessary sensitization risk.

ASTM stands for the American Society for Testing and Materials. It is the internationally recognized standards organization responsible for developing and publishing voluntary consensus standards for materials, products, systems, and services across a wide range of industries — including medical devices, healthcare PPE, and laboratory equipment. ASTM compliance for a product like Posi-Shield Advanced signals that it has been independently evaluated against rigorous, industry-accepted performance and safety benchmarks.